The United States represents the largest share of the Small Molecule Drug Discovery Market, driven by its advanced pharmaceutical ecosystem, substantial research and development investments, and strong presence of leading biotechnology and pharmaceutical companies. The country benefits from a highly developed healthcare infrastructure, favorable regulatory environment, and increasing adoption...